Trelegy Ellipta 62.5 ug/1 62.5 ug/1 POWDER

Trelegy Ellipta 62.5 ug/1

Active Ingredient:
fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
Form:
POWDER
Brand:
Trelegy Ellipta
Origin:
USA

Buy Trelegy Ellipta 62.5 ug/1 fluticasone furoate, umeclidinium bromide and vilanterol trifenatate

Trelegy Ellipta 62.5 ug/1 is a combination inhaler containing fluticasone furoate, umeclidinium bromide, and vilanterol trifenatate. It is designed for respiratory conditions, offering a convenient once-daily treatment option. This inhaler is manufactured by GlaxoSmithKline LLC and is available in a 30-dose pack.

Strength

62.5 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0893-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER

Manufacturer

GlaxoSmithKline LLC

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Trelegy Ellipta 62.5 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The combination of fluticasone furoate, umeclidinium bromide, and vilanterol trifenatate works to reduce inflammation, relax airway muscles, and improve breathing. This inhaler is often prescribed for individuals who require a combination of these active ingredients to manage their respiratory symptoms effectively.

Side Effects

  • Common effects of Trelegy Ellipta 62.5 ug/1 may include throat irritation, headache, and a dry mouth. Some users might experience hoarseness or a cough shortly after inhalation. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

  • Trelegy Ellipta 62.5 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure safety and effectiveness. Patients with certain medical conditions, such as severe asthma or heart problems, should discuss their use of this inhaler with their doctor before starting treatment.

Avoid Interactions

  • Trelegy Ellipta 62.5 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

References

Frequently Asked Questions

Trelegy Ellipta 62.5 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma.

Trelegy Ellipta 62.5 ug/1 is administered via inhalation, typically once daily. Follow the instructions provided by your healthcare professional.

Common side effects may include throat irritation, headache, and a dry mouth. These effects are usually mild and temporary.

Trelegy Ellipta 62.5 ug/1 may interact with other medications, so it is important to discuss all your current medications with your healthcare provider.

Trelegy Ellipta 62.5 ug/1 may not be suitable for everyone, especially those with severe asthma or heart problems. Consult your healthcare professional for personalized advice.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use.

If you wish to request the removal of a product or any part of its content, please contact us at legal@gnhindia.com.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT